Company Filing History:
4 out of 1,991 
2 out of 269 
1 out of 327 Years Active: 2015-2022
Title: Ioannis Danias: Innovator in Glaucoma Treatment
Introduction
Ioannis Danias is a notable inventor based in Staten Island, NY (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. With a total of 4 patents to his name, Danias is recognized for his innovative approaches to managing intraocular pressure (IOP)-associated conditions.
Latest Patents
Danias's latest patents focus on methods for treating glaucoma through the administration of tissue plasminogen activator (tPA) therapeutic agents. These methods aim to effectively reduce IOP in subjects for extended periods, ranging from one day to a year or more. The tPA therapeutic agent can include tPA, its derivatives, small molecule agonists, or even gene therapy vectors, showcasing a versatile approach to glaucoma treatment.
Career Highlights
Throughout his career, Ioannis Danias has worked with esteemed institutions such as the State University of New York and the Icahn School of Medicine at Mount Sinai. His work in these organizations has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research.
Collaborations
Danias has collaborated with notable colleagues, including Oscar A. Candia and Rosana Gerometta. These partnerships have further enriched his research and development efforts in glaucoma treatment.
Conclusion
Ioannis Danias stands out as an innovative inventor in the medical field, particularly in glaucoma treatment. His contributions through patents and collaborations continue to impact the way IOP-associated conditions are managed.